Investigation of SP1 and SP3 Expressions in Colorectal Cancer Carcinogenesis

被引:0
|
作者
Gurer, Turkan [1 ]
Al-Doori, Ibrahim [1 ]
Aytekin, Alper [2 ]
Mihcioglu, Deniz [3 ]
机构
[1] Gaziantep Univ, Fac Art & Sci, Dept Biol, TR-27310 Gaziantep, Turkey
[2] Gaziantep Univ, Sch Med, Dept Gen Surg, TR-27310 Gaziantep, Turkey
[3] SANKO Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-27090 Gaziantep, Turkey
关键词
Colorectal Tumour; Gene Expression; Specificity Protein 1; Specificity Protein 3; Transcription Factors; TRANSCRIPTION FACTOR SP1; GENE-EXPRESSION; SURVIVAL; LEADS;
D O I
10.31901/24566330.2021/21.03.777
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The study aimed to determine the expressions of SP1 and SP3 and the clinical-pathological characteristics of patients, and the correlation between the expressions of Specificity Protein 1 (SP1) and Specificity Protein 3 (SP3) in colorectal cancer (CRC). In this study, tumour and adjacent non-tumour tissue samples were obtained from 41 individuals with CRC. SP1 and SP3 expressions were performed using Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR). According to the results of our study, there was no statistically significant difference in SP1 and SP3 expression levels between tumour tissues and non-tumour tissues (p>0.05), as well as no association with clinicalpathological features of patients. In addition, a high positive correlation was found between the expressions of SP1 and SP3 genes in CRC (p=0.01). Consequently, it can be said that there is a correlation between SP1 and SP3 expressions, but SP1 and SP3 expressions are not related to CRC carcinogenesis.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 50 条
  • [21] Regulation of human monoamine oxidase B gene by Sp1 and Sp3
    Wong, WK
    Chen, K
    Shih, JC
    MOLECULAR PHARMACOLOGY, 2001, 59 (04) : 852 - 859
  • [22] Sp1 and Sp3 activate transcription of the human dopamine transporter gene
    Wang, J
    Bannon, MJ
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 474 - 482
  • [23] N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3
    Tuthill, MC
    Wada, RK
    Arimoto, JM
    Sugino, CN
    Kanemaru, KK
    Takeuchi, KK
    Sidell, N
    MOLECULAR GENETICS AND METABOLISM, 2003, 80 (1-2) : 272 - 280
  • [24] Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
    Jane Gilmour
    Leigh O’Connor
    Christopher P. Middleton
    Peter Keane
    Nynke Gillemans
    Jean-Baptiste Cazier
    Sjaak Philipsen
    Constanze Bonifer
    Epigenetics & Chromatin, 12
  • [25] Docking and molecular dynamic simulations of mithramycin against Sp1, Sp3, and survivin
    Lambring, Christoffer Briggs
    Behera, Santosh K.
    Basha, Riyaz
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
    Gilmour, Jane
    O'Connor, Leigh
    Middleton, Christopher P.
    Keane, Peter
    Gillemans, Nynke
    Cazier, Jean-Baptiste
    Philipsen, Sjaak
    Bonifer, Constanze
    EPIGENETICS & CHROMATIN, 2019, 12 (1)
  • [27] Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1
    Kumar, AP
    Butler, AP
    NUCLEIC ACIDS RESEARCH, 1997, 25 (10) : 2012 - 2019
  • [28] Sp1 and Sp3 activate the rat connexin40 proximal promoter
    Teunissen, BEJ
    van Amersfoorth, SCM
    Opthof, T
    Jongsma, HJ
    Bierhuizen, MFA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (01) : 71 - 78
  • [29] The role of Sp1 and Sp3 in the regulation of estrogen-responsive genes in breast cancer cell lines
    不详
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2005, 83 (06): : 778 - 779
  • [30] Sp1和Sp3介导的转录调控
    薛丽香
    翁默
    吴军峰
    张宗玉
    童坦君
    中国生物化学与分子生物学报, 2006, (02) : 106 - 110